Breaking News Instant updates and real-time market news.

INO

Inovio

$5.06

-0.1 (-1.94%)

04:55
04/16/18
04/16
04:55
04/16/18
04:55

Inovio management to meet with RBC Capital

Meeting to be held in Chicago on April 16 hosted by RBC Capital.

  • 16

    Apr

INO Inovio
$5.06

-0.1 (-1.94%)

10/18/17
RBCM
10/18/17
INITIATION
RBCM
Outperform
Inovio initiated with an Outperform at RBC Capital
RBC Capital analyst Matthew Eckler initiated Inovio with an Outperform and $11 price target saying Phase III asset VGX-3100 has potential to be the first non-surgical approach for the treatment of HPV-driven cervical pre-cancers. Eckler also believes Inovio's early immuno-oncology platform also offer significant upside if any of the ongoing Phase1/Phase trials generate encouraging results.
10/18/17
10/18/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Aaron's (AAN) initiated with a Neutral at Janney Capital. 2. Inovio (INO) initiated with an Outperform at RBC Capital. 3. Carrizo Oil & Gas (CRZO) reinstated with a Neutral at Goldman Sachs. 4. Goodrich Petroleum (GDP) assumed with a Buy at Seaport Global. 5. Krystal Biotech (KRYS) initiated with a Buy at Ladenburg. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/15/18
RBCM
03/15/18
NO CHANGE
Target $14
RBCM
Outperform
Inovio price target raised to $14 on pipeline progress at RBC Capital
RBC Capital analyst Gregory Renza raised his price target for Inovio to $14 from $11, citing confidence in the company's portfolio progress after the timelines were reiterated for lead VGX-3100's Phase III program in CIN toward a 2020 first data look, with global site set-up on track and enabled for recruitment. The analyst reiterates an Outperform rating on the shares.
03/15/18
RBCM
03/15/18
NO CHANGE
Target $14
RBCM
Outperform
Inovio price target raised to $14 from $11 at RBC Capital
RBC Capital analyst Gregory Renza raised his price target for Inovio Pharmaceuticals to $14 citing model updates following the company's Q4 results. Inovio is confident in its portfolio progress and management reiterated timelines for lead VGX-3100's Phase III program, Renza tells investors in a post-earnings research note. He reiterates an Outperform rating on Inovio shares.

TODAY'S FREE FLY STORIES

OPGN

OpGen

$1.91

-0.01 (-0.52%)

17:45
10/15/18
10/15
17:45
10/15/18
17:45
Earnings
OpGen says preliminary Q3 revenue $550K vs. $750K in Q317 »

Total preliminary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPX

Tempur Sealy

$47.87

0.03 (0.06%)

, SHLD

Sears

$0.31

-0.0901 (-22.52%)

17:44
10/15/18
10/15
17:44
10/15/18
17:44
Hot Stocks
Tempur Sealy: Sears represented less than 5% of company's global net sales »

In connection with the…

TPX

Tempur Sealy

$47.87

0.03 (0.06%)

SHLD

Sears

$0.31

-0.0901 (-22.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$115.95

0.71 (0.62%)

17:42
10/15/18
10/15
17:42
10/15/18
17:42
Hot Stocks
SPDR Gold Trust rise to 748.76MT from 744.64MT »

This is the 2nd…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IGC

India Globalization Capital

$5.30

0.35 (7.07%)

17:35
10/15/18
10/15
17:35
10/15/18
17:35
Syndicate
Breaking Syndicate news story on India Globalization Capital »

India Globalization…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

RWLK

ReWalk Robotics

$0.81

-0.0038 (-0.47%)

17:34
10/15/18
10/15
17:34
10/15/18
17:34
Syndicate
Breaking Syndicate news story on ReWalk Robotics »

ReWalk Robotics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZBH

Zimmer Biomet

$123.59

0.12 (0.10%)

17:34
10/15/18
10/15
17:34
10/15/18
17:34
Initiation
Zimmer Biomet initiated  »

Zimmer Biomet initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 26

    Oct

RIO

Rio Tinto

$49.54

0.34 (0.69%)

17:34
10/15/18
10/15
17:34
10/15/18
17:34
Hot Stocks
Breaking Hot Stocks news story on Rio Tinto »

Rio Tinto sees Pilbara…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TFX

Teleflex

$249.10

0.64 (0.26%)

17:33
10/15/18
10/15
17:33
10/15/18
17:33
Initiation
Teleflex initiated  »

Teleflex initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

RIO

Rio Tinto

$49.54

0.34 (0.69%)

17:33
10/15/18
10/15
17:33
10/15/18
17:33
Hot Stocks
Rio Tinto reports Q3 Pilbara iron ore output 82.5M tons, down 3% from last year »

Pilbara iron ore…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYK

Stryker

$169.42

-1.66 (-0.97%)

17:33
10/15/18
10/15
17:33
10/15/18
17:33
Initiation
Stryker initiated  »

Stryker initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

MDT

Medtronic

$93.81

-0.85 (-0.90%)

17:32
10/15/18
10/15
17:32
10/15/18
17:32
Initiation
Medtronic initiated  »

Medtronic initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$238.05

-10.84 (-4.36%)

17:31
10/15/18
10/15
17:31
10/15/18
17:31
Hot Stocks
Adobe says it is expanding creative cloud to non-professionals »

Says over the last few…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

HRC

Hill-Rom

$87.26

-1.04 (-1.18%)

17:30
10/15/18
10/15
17:30
10/15/18
17:30
Initiation
Hill-Rom initiated  »

Hill-Rom initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

EW

Edwards Lifesciences

$141.95

-1.44 (-1.00%)

17:29
10/15/18
10/15
17:29
10/15/18
17:29
Initiation
Edwards Lifesciences initiated  »

Edwards Lifesciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

CNMD

CONMED

$73.17

0.73 (1.01%)

17:28
10/15/18
10/15
17:28
10/15/18
17:28
Initiation
CONMED initiated  »

CONMED initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

TTOO

T2 Biosystems

$5.30

0.17 (3.31%)

17:27
10/15/18
10/15
17:27
10/15/18
17:27
Syndicate
Breaking Syndicate news story on T2 Biosystems »

T2 Biosystems files $100M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$36.43

-0.56 (-1.51%)

17:26
10/15/18
10/15
17:26
10/15/18
17:26
Initiation
Boston Scientific initiated  »

Boston Scientific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

BDX

Becton Dickinson

$238.38

-4.33 (-1.78%)

17:25
10/15/18
10/15
17:25
10/15/18
17:25
Initiation
Becton Dickinson initiated  »

Becton Dickinson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

BAX

Baxter

$70.88

-0.39 (-0.55%)

17:24
10/15/18
10/15
17:24
10/15/18
17:24
Initiation
Baxter initiated  »

Baxter initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 23

    Oct

  • 31

    Oct

CRMD

CorMedix

$2.15

-0.12 (-5.29%)

17:23
10/15/18
10/15
17:23
10/15/18
17:23
Syndicate
Breaking Syndicate news story on CorMedix »

CorMedix files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVNS

Avanos

$60.02

0.59 (0.99%)

17:22
10/15/18
10/15
17:22
10/15/18
17:22
Initiation
Avanos initiated  »

Avanos initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$68.72

-0.62 (-0.89%)

17:19
10/15/18
10/15
17:19
10/15/18
17:19
Initiation
Abbott initiated  »

Abbott initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

SBBX

SB One Bancorp

$24.00

-0.27 (-1.11%)

17:19
10/15/18
10/15
17:19
10/15/18
17:19
Hot Stocks
Breaking Hot Stocks news story on SB One Bancorp »

EJF Capital reports 5.5%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HQCL

Hanwah Q Cells

$8.20

-0.13 (-1.56%)

17:07
10/15/18
10/15
17:07
10/15/18
17:07
Hot Stocks
Hanwah Q Cells up 8.5% after agreeing to be acquired by Hanwha Solar »

In after-hours trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBRX

Moleculin Biotech

$1.38

-0.005 (-0.36%)

17:06
10/15/18
10/15
17:06
10/15/18
17:06
Syndicate
Breaking Syndicate news story on Moleculin Biotech »

Moleculin Biotech files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.